Daxor Corp
NASDAQ:DXR
Daxor Corp
Operating Expenses
Daxor Corp
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Daxor Corp
NASDAQ:DXR
|
Operating Expenses
-$222.1k
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
-2%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Expenses
-$6.4B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Expenses
-$8.5B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
|
Stryker Corp
NYSE:SYK
|
Operating Expenses
-$9.5B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Expenses
-$16.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Expenses
-$3.3B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-14%
|
|
Daxor Corp
Glance View
Daxor Corp. is a biotechnology company which develops and manufactures the BVA-100 blood volume analyzer, an instrument that measures human blood volume. The company is headquartered in New York City, New York. The Company’s investment objectives are capital preservation, maintaining returns on capital with a high degree of safety and generating income from dividends and option sales to help offset operating losses from the Company’s operating division. The firm intends to maintain a diversified securities portfolio comprised primarily of electric utility company common and preferred stocks. The firm seeks to maintain a minimum of 80% of its portfolio in equity securities of utility companies.
See Also
What is Daxor Corp's Operating Expenses?
Operating Expenses
-222.1k
USD
Based on the financial report for Dec 31, 2024, Daxor Corp's Operating Expenses amounts to -222.1k USD.
What is Daxor Corp's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-2%
Over the last year, the Operating Expenses growth was 7%. The average annual Operating Expenses growth rates for Daxor Corp have been -23% over the past three years , -49% over the past five years , and -2% over the past ten years .
You don't have any saved screeners yet